Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,760 | 87 | 98.9% |
| Education | $19.48 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sumitomo Pharma America, Inc. | $255.41 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $194.88 | 11 | $0 (2024) |
| 180 Medical, Inc. | $110.42 | 5 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $109.65 | 7 | $0 (2023) |
| Axonics, Inc. | $109.30 | 4 | $0 (2024) |
| Myovant Sciences Inc. | $109.15 | 6 | $0 (2022) |
| ACCORD HEALTHCARE, INC. | $106.80 | 4 | $0 (2024) |
| Rochester Medical Corporation | $86.91 | 2 | $0 (2022) |
| Antares Pharma, Inc. | $58.85 | 4 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $56.88 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $597.40 | 28 | Sumitomo Pharma America, Inc. ($112.60) |
| 2023 | $591.05 | 28 | Sumitomo Pharma America, Inc. ($142.81) |
| 2022 | $477.88 | 24 | Rochester Medical Corporation ($86.91) |
| 2021 | $113.51 | 8 | Myovant Sciences Inc. ($25.38) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: HORMONE THERAPY | ||||||
| 11/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: HORMONE THERAPY | ||||||
| 10/15/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: Urology | ||||||
| 10/08/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $29.54 | General |
| 09/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: HORMONE THERAPY | ||||||
| 09/03/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $34.19 | General |
| Category: Urology | ||||||
| 08/29/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: HORMONE THERAPY | ||||||
| 08/27/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: HORMONE THERAPY | ||||||
| 07/23/2024 | Solventum Corporation | 3M Cavilon (Device), PREVENA | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: Skin Integrity | ||||||
| 07/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/09/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $27.58 | General |
| Category: ONCOLOGY | ||||||
| 07/02/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $21.89 | General |
| 06/12/2024 | Solventum Corporation | 3M Cavilon (Device), PREVENA, V.A.C. VERAFLO CLEANSE CHOICE | Food and Beverage | Cash or cash equivalent | $19.85 | General |
| Category: Skin Integrity | ||||||
| 05/16/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/09/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 03/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Oncology | ||||||
| 02/27/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,023 | 3,930 | $220,943 | $58,455 |
| 2022 | 7 | 917 | 1,242 | $156,712 | $40,085 |
| 2021 | 16 | 921 | 1,282 | $203,631 | $56,629 |
| 2020 | 12 | 513 | 751 | $119,516 | $29,316 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 119 | 151 | $52,397 | $16,138 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 193 | $49,794 | $13,660 | 27.4% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 17 | 127 | $37,592 | $8,536 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 123 | 151 | $26,274 | $7,950 | 30.3% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 11 | 2,400 | $16,800 | $5,295 | 31.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 270 | 399 | $14,763 | $2,757 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $5,096 | $1,285 | 25.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 279 | 443 | $11,075 | $961.70 | 8.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 19 | $3,344 | $939.54 | 28.1% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 18 | 34 | $3,808 | $934.56 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 149 | 189 | $65,583 | $18,254 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 154 | $39,732 | $11,048 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 126 | $21,924 | $6,192 | 28.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 226 | 328 | $12,136 | $2,181 | 18.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 278 | 409 | $10,225 | $902.50 | 8.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,312 | $878.23 | 20.4% |
| 51701 | Insertion of temporary bladder tube | Office | 2022 | 16 | 25 | $2,800 | $629.67 | 22.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 185 | 248 | $86,056 | $26,675 | 31.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 152 | $39,216 | $11,330 | 28.9% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2021 | 14 | 90 | $18,090 | $4,769 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 74 | $12,876 | $3,748 | 29.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 20 | 20 | $9,860 | $2,642 | 26.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $7,448 | $1,522 | 20.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 232 | 353 | $8,825 | $1,176 | 13.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 20 | 45 | $4,230 | $1,115 | 26.4% |
About Chandra Marlin, NP
Chandra Marlin, NP is a Family healthcare provider based in Columbus, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1881237808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chandra Marlin, NP has received a total of $1,780 in payments from pharmaceutical and medical device companies, with $597.40 received in 2024. These payments were reported across 88 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($1,760).
As a Medicare-enrolled provider, Marlin has provided services to 3,374 Medicare beneficiaries, totaling 7,205 services with total Medicare billing of $184,485. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Columbus, IN
- Active Since 10/22/2019
- Last Updated 06/12/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881237808
Products in Payments
- ORGOVYX (Drug) $268.64
- Nubeqa (Drug) $194.88
- GEMTESA (Drug) $117.34
- CAMCEVI (Drug) $106.80
- XIAFLEX (Biological) $101.91
- Axonics (Device) $91.64
- XYOSTED (Drug) $58.85
- PYLARIFY (Drug) $56.88
- YONSA (Drug) $42.67
- LoFric (Device) $41.94
- 3M Cavilon (Device) $40.49
- ELIGARD (Drug) $39.84
- INTERSTIM (Device) $37.85
- Prolaris (Device) $35.53
- AVEED (Biological) $33.49
- PROVENGE (Drug) $29.39
- AQUABEAM ROBOTIC SYSTEM (Device) $27.10
- Glydo (Drug) $26.06
- OXLUMO (Drug) $19.48
- XTANDI (Drug) $17.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Columbus
Teresa Miller, Cnp, CNP
Family — Payments: $26,526
Beth Loessin
Family — Payments: $17,544
Eileen Faulds, Aprncnp, APRNCNP
Family — Payments: $13,709
Tarsicio Gacheru, Cnp, CNP
Family — Payments: $13,480
Toni Seibert, Apn, APN
Family — Payments: $13,241
Mary Hurley, Np-C, NP-C
Family — Payments: $11,853